acetylcysteine has been researched along with Kidney Failure, Chronic in 83 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.20) | 18.7374 |
| 1990's | 1 (1.20) | 18.2507 |
| 2000's | 49 (59.04) | 29.6817 |
| 2010's | 27 (32.53) | 24.3611 |
| 2020's | 5 (6.02) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, F; Meng, X; Shao, Z | 1 |
| Biswas, S; Roy, T; Sengupta, P | 1 |
| Cepaityte, D; Leivaditis, K; Liakopoulos, V; Roumeliotis, A; Roumeliotis, S; Varouktsi, G | 1 |
| Abdulazim, DO; Amin, M; Csongradi, E; ElAzim, IMA; Elhadidy, S; Fayed, A; Hammad, AA; Hammad, H; Salem, MM; Sharaf El Din, UA; Soliman, KM; Zsom, L | 1 |
| Anderson, EM; Berceli, SA; Cort, TA; Dong, G; Fazzone, B; Kim, K; Kunz, EM; Moerschel, J; Moparthy, CN; O'Malley, KA; Palzkill, VR; Robinson, ST; Ryan, TE; Scali, ST | 1 |
| Chien, WC; Chung, CH; Liao, CY; Lin, FH; Tsao, CH; Wang, CC; Wu, CC | 1 |
| Li, X; Pei, F; Wan, C; Wu, Y; Xue, R; Zhan, Y | 1 |
| Breborowicz, A; Mackowiak, B; Sosinska-Zawierucha, P | 1 |
| Alatab, S; Ganji, MR; Pasha, F; Saddadi, F; Soleimanian, T | 1 |
| Bortolotto, LA; De Lima, JJ; Drager, LF; Gaiotto, FA; Gowdak, LH; Hajjar, LA; Puig, LB; Santana-Santos, E; Shimizu, MH; Zeferino, SP | 1 |
| Aydemir, S; İlhan Sahin, M; Kocyigit, I; Oymak, O; Sipahioglu, MH; Tokgoz, B; Unal, A; Vural, A; Yazici, C; Yucel, HE | 1 |
| Castilho, G; Catanozi, S; Fusco, FB; Iborra, RT; Machado, JT; Machado-Lima, A; Nakandakare, ER; Passarelli, M; Pinto, RS; Seguro, AC; Shimizu, MH | 1 |
| Benck, U; Krämer, BK; Mundt, HM; Schnülle, P; Yard, BA | 1 |
| Ghorbani, A; Shahbazian, H; Shayanpour, S | 1 |
| Huang, T; Wang, L; Xu, G; Yan, W | 1 |
| Bashir, I; DeLago, A; El-Hajjar, M; Khan, M; Min, J; Torosoff, M | 1 |
| Hörl, WH | 1 |
| Burkert, M; Scholze, A; Tepel, M; Wittstock, A; Zidek, W | 1 |
| Barone, MT; Danna, P; Ferrario, F; Genderini, A; Heidemperger, M; Landoni, G; Piccaluga, E; Scorza, D; Trezzi, M | 1 |
| Butnaru, A; Korenfeld, R; Lifschitz, M; Shavit, L; Slotki, I | 1 |
| Blasco, M; Carbonell, N; Jordá, A; Miguel, A; Sanjuán, R | 1 |
| Argirov, M; Merkle, M; Sauter, M; Wörnle, M | 1 |
| Himmelfarb, J; McMenamin, ME; Nolin, TD; Ouseph, R; Ward, RA | 1 |
| Cutler, M; Freeman, D; Gallo, K; House, AA; Mainra, R; Moist, L; Sontrop, JM | 1 |
| Aleksandrowicz, E; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Łysiak-Szydłowska, W | 1 |
| Chiang, CK; Chien, CT; Hsu, SP; Yang, SY | 1 |
| Adijiang, A; Bolati, D; Dateki, M; Enomoto, A; Nishijima, F; Niwa, T; Shimizu, H | 1 |
| Atem, F; Cho, R; Javed, N; Kodali, S; Srinivasan, V; Traub, D | 1 |
| Alouane, Z; Bahadi, A; El Kabbaj, D; Laalou, A; Oualim, Z | 1 |
| De Santo, NG; Ingrosso, D; Lanza, D; Perna, AF; Pollastro, RM; Sepe, I | 1 |
| Abaterusso, C; Bellinghieri, G; Cirillo, G; Cirillo, M; Coppola, S; De Santo, NG; Di Iorio, B; Ingrosso, D; Lanza, D; Lupo, A; Perna, AF; Raiola, I; Raiola, P; Santoro, D; Satta, E; Savica, V; Sepe, I; Tirino, G; Violetti, E | 1 |
| Binder, C; Jaberi, A; Kitzler, TM; Kotanko, P; Petnehazy, E; Rehak, P; Sendlhofer, G; Stacher, R | 1 |
| Beberashvili, I; Feldman, L; Shani, M; Sinuani, I; Weissgarten, J | 1 |
| Prasetyo, DH; Purwanto, B | 1 |
| Andrade, L; Leite, CC; Pereira, LV; Rodrigues, LP; Seguro, AC; Shimizu, MH | 1 |
| Grutzmacher, C; Morrison, ME; Park, S; Sheibani, N; Sorenson, CM; Zhao, Y | 1 |
| Henze, A; Raila, J; Scholze, A; Schweigert, FJ; Tepel, M; Zidek, W | 1 |
| Cheng, JJ; Kuan, P; Shyu, KG | 1 |
| Amhad, M; Boccalandro, F; Sdringola, S; Smalling, RW | 1 |
| Dean, LS | 1 |
| Jankowski, J; Statz, M; Tepel, M; van der Giet, M; Zidek, W | 1 |
| Kellum, JA | 1 |
| Birck, R; Braun, C; Krzossok, S; Markowetz, F; Schnülle, P; van der Woude, FJ | 1 |
| Rezkalla, SH | 1 |
| Howe, AM; Macon, EJ; Raven, QL; Walton, T | 1 |
| Averbukh, M; Blatt, A; Dishy, V; Efrati, S; Golik, A; Krakover, R; Morrow, JD; Stein, MC; Weisgarten, J | 1 |
| Alonso, A; Jaber, BL; Lau, J; Sarnak, MJ; Weintraub, A | 1 |
| Boitte, S; De Kock, M; Hanet, CE; Kefer, JM; Wilmotte, L | 1 |
| Beige, J; Riezler, R; Rinder, C; Scholze, A; Tepel, M; Zidek, W | 1 |
| Robinson, K | 1 |
| Meine, TJ; Washam, JB | 1 |
| Andrade, L; Barros de Toledo, JF; Drager, LF; Laurindo, FR; Machado César, LA; Seguro, AC | 1 |
| Agarwal, R; Chase, S; Sachs, NG; Vasavada, N | 1 |
| Genest, M; Pochmalicki, G | 1 |
| Batisse, JP; Beygui, F; El Mahmoud, R; Helft, G; Le Feuvre, C; Le Quan Sang, KH; Metzger, JP | 1 |
| Tepel, M; Zidek, W | 2 |
| Agarwal, R; Chebrolu, S; Leehey, DJ; Palubiak, DJ | 1 |
| Bartorelli, AL; Marenzi, G | 1 |
| Gabutti, L; Marone, C; Marzo, A; Soldini, D; Zwahlen, H | 1 |
| Bobkowski, W; Dobrowolska-Zachwieja, A; Lewandowska-Stachowiak, M; Ostalska-Nowicka, D; Siwińska, A; Stefaniak, E; Warzywoda, A; Zachwieja, J; Zaniew, M | 1 |
| Lewandowska-Stachowiak, M; Runowski, D; Stefaniak, E; Warzywoda, A; Zachwieja, J; Zaniew, M | 1 |
| Balderramo, DC; Cremona, LS; Eduardo, M; Lemos, PA; Orías, M; Ramacciotti, CF; Verdu, MB | 1 |
| Coimbra, TM; de Araujo, M; Menezes, LF; Seguro, AC; Shimizu, MH | 1 |
| Lewandowska-Stachowiak, M; Siwińska, A; Sobczyk, D; Zachwieja, J; Zaniew, M | 1 |
| Kuitunen, A; Kuitunen, T; Pöyhiä, R; Ristikankare, A; Salmenperä, M; Suojaranta-Ylinen, R; Uotila, L; Vento, A | 1 |
| Ambros-Rudolph, CM; Di Stefani, A; Massone, C; Müllegger, RR | 1 |
| Thaha, M; Tomino, Y; Yogiantoro, M | 1 |
| Shehabi, Y | 1 |
| Abramsohn, R; Averbukh, Z; Efrati, S; Eviatar, E; Feldman, L; Gersch, E; Weissgarten, J; Yarovoy, I | 1 |
| Flynn, F; Georghiou, M; Jaggar, S; Morgan, PG | 1 |
| Gugliucci, A; Kimura, S; Kinugasa, E; Lunceford, N; Ogata, H; Schulze, J | 1 |
| Tepel, M | 1 |
| DeRose, G; Elliot, J; Forbes, TL; Harris, KA; Kribs, SW; Lawlor, DK; Lovell, MB; Moist, L | 1 |
| Balkin, J; Lachish, T; Lifschitz, M; Rosenmann, D; Shavit, L; Slotki, I | 1 |
| Capasso, R; De Santo, NG; Ingrosso, D; Lombardi, C; Luciano, MG; Perna, AF; Pulzella, P; Satta, E | 1 |
| Pranawa, W; Thaha, M; Tomino, Y; Yogiantoro, M | 1 |
| Barr, LF; Kolodner, K | 1 |
| Bostom, AG; Fisher, DH; Nadeau, MR; Selhub, J; Shemin, D; Yoburn, D | 1 |
| Laufer, U; Liermann, D; Schwarzfeld, C; Tepel, M; van der Giet, M; Zidek, W | 1 |
| Andrade, L; Safirstein, R; Vieira, JM | 1 |
| Rizzato, G | 1 |
| Levy, G | 1 |
10 review(s) available for acetylcysteine and Kidney Failure, Chronic
| Article | Year |
|---|---|
N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Humans; Kidney Failure, Chronic; Oxidative Stress; Reactive Oxygen Species; Renal Insufficiency, Chronic | 2023 |
Optimized donor management and organ preservation before kidney transplantation.
Topics: Acetylcysteine; Animals; Antioxidants; Brain Death; Deamino Arginine Vasopressin; Delayed Graft Function; Dopamine; Graft Survival; Humans; Immune System; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone; Organ Preservation; Randomized Controlled Trials as Topic; Recombinant Proteins; Resuscitation; Superoxide Dismutase; Thyroid Hormones; Tissue and Organ Procurement; Tissue Donors | 2016 |
[Contrast induced nephropathy].
Topics: Acetylcysteine; Acute Kidney Injury; Algorithms; Contrast Media; Creatinine; Critical Care; Fluid Therapy; Glomerular Filtration Rate; Hospital Mortality; Humans; Kidney Failure, Chronic; Osmolar Concentration; Renal Dialysis; Risk Factors; Sodium Bicarbonate; Theophylline | 2009 |
Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
Topics: Acetylcysteine; Cardiovascular Diseases; Drug Resistance; Folic Acid; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Renal Dialysis; Risk Factors | 2012 |
Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Cysteine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Outcome Assessment, Health Care; Radiography; Randomized Controlled Trials as Topic | 2003 |
Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Cystine; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Tomography, X-Ray Computed | 2004 |
[Diagnostic and therapeutic progress. Venous thromboembolism, cardiac insufficiency and radio contrast agents].
Topics: Acetylcysteine; Acute Disease; Adrenergic beta-Antagonists; Anticoagulants; Counterpulsation; Diastole; Diuretics; Echocardiography; Electric Countershock; Fibrin Fibrinogen Degradation Products; Fluid Therapy; Heart Failure; Hemofiltration; Heparin; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Oxygen Inhalation Therapy; Pulmonary Edema; Thromboembolism; Tissue Plasminogen Activator; Treatment Outcome; Vasodilator Agents; Venous Thrombosis | 2004 |
N-Acetylcysteine in nephrology; contrast nephropathy and beyond.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Contrast Media; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic | 2004 |
Recent advances in the prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Bicarbonates; Clinical Trials as Topic; Contrast Media; Hemofiltration; Humans; Isotonic Solutions; Kidney Failure, Chronic; Radiography; Renal Circulation | 2004 |
Acetylcysteine for radiocontrast nephropathy.
Topics: Acetylcysteine; Animals; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubules; Reactive Oxygen Species | 2001 |
40 trial(s) available for acetylcysteine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Efficacy and safety of mesenchymal stem cell in Chinese patients with chronic renal failure: A pilot study in Shandong province, China.
Topics: Acetylcysteine; Aged; China; Creatinine; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Mesenchymal Stem Cell Transplantation; Middle Aged; Pilot Projects; Transplantation, Autologous; Treatment Outcome | 2021 |
Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney D
Topics: Acetylcysteine; Adult; Aged; Diet, Protein-Restricted; Dietary Supplements; Disease Progression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxamine; Renal Insufficiency, Chronic; Taurine | 2022 |
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study.
Topics: Acetylcysteine; Acute Kidney Injury; Allopurinol; Chemoprevention; Contrast Media; Diabetic Nephropathies; Drug Therapy, Combination; Humans; Kidney Failure, Chronic; Linagliptin; Prospective Studies; Protective Agents; Renal Insufficiency, Chronic; Saline Solution | 2023 |
The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Down-Regulation; Female; Humans; Inflammation Mediators; Interleukin-6; Iran; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors; Treatment Outcome | 2014 |
High dose of N-acetylcystein prevents acute kidney injury in chronic kidney disease patients undergoing myocardial revascularization.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Cardiopulmonary Bypass; Confidence Intervals; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospital Mortality; Humans; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Pulse Therapy, Drug; Radiography; Reference Values; Risk Assessment; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2014 |
Preventing amikacin related ototoxicity with N-acetylcysteine in patients undergoing peritoneal dialysis.
Topics: Acetylcysteine; Amikacin; Anti-Bacterial Agents; Ear Diseases; Female; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Male; Middle Aged; Otoacoustic Emissions, Spontaneous; Peritoneal Dialysis; Peritonitis; Prospective Studies | 2015 |
Evaluation of administration of oral N-acetylcysteine to reduce oxidative stress in chronic hemodialysis patients: A double-blind, randomized, controlled clinical trial.
Topics: Acetylcysteine; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Male; Oxidative Stress; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2016 |
Treatment for non-thyroidal illness syndrome in advanced chronic kidney disease: a single-blind controlled study.
Topics: Acetylcysteine; Chi-Square Distribution; China; Disease Progression; Euthyroid Sick Syndromes; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Single-Blind Method; Sodium Bicarbonate; Time Factors; Treatment Outcome | 2017 |
N-acetylcysteine improves arterial vascular reactivity in patients with chronic kidney disease.
Topics: Acetylcysteine; Aged; Female; Humans; Kidney Failure, Chronic; Male; Peripheral Vascular Diseases; Placebo Effect | 2009 |
Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Topics: Acetylcysteine; Aged; Contrast Media; Female; Free Radical Scavengers; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Osmolar Concentration; Prospective Studies | 2009 |
Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
Topics: Acetylcysteine; Aged; Cardiac Catheterization; Contrast Media; Creatine; Dehydration; Female; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Prospective Studies; Regression Analysis; Risk Assessment; Sodium Bicarbonate; Sodium Chloride; Statistics as Topic | 2009 |
N-acetylcysteine: short-term clinical benefits after coronary angiography in high-risk renal patients.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Double-Blind Method; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Prospective Studies; Risk Factors; Time Factors | 2010 |
Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.
Topics: Acetylcysteine; Administration, Oral; Adult; Antioxidants; Area Under Curve; Biomarkers; Delayed-Action Preparations; Down-Regulation; Female; Half-Life; Homocysteine; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Oxidative Stress; Prospective Studies; Treatment Outcome; United States | 2010 |
Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
Topics: Acetylcysteine; Administration, Oral; Aged; Aged, 80 and over; Confidence Intervals; Creatinine; Cystatin C; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2010 |
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Albuminuria; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Diabetes Complications; Female; Free Radical Scavengers; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Placebos; Proteins; Risk Factors; Sodium; Young Adult | 2010 |
N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Antioxidants; Case-Control Studies; Chlorides; Dinoprost; Erythropoietin; Female; Ferric Compounds; Hematocrit; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis | 2010 |
Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Analysis of Variance; Bicarbonates; Buffers; Confidence Intervals; Contrast Media; Cross-Over Studies; Female; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Length of Stay; Male | 2010 |
Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Double-Blind Method; Female; Free Radical Scavengers; Humans; Iohexol; Kidney Failure, Chronic; Male; Treatment Outcome; Vitamin E | 2012 |
N-acetylcysteine may improve residual renal function in hemodialysis patients: a pilot study.
Topics: Acetylcysteine; Aged; Female; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Metabolic Clearance Rate; Peritoneal Dialysis; Pilot Projects; Renal Dialysis | 2012 |
Effect of oral N-acetylcysteine treatment on immune system in continuous ambulatory peritoneal dialysis patients.
Topics: Acetylcysteine; Adult; Antioxidants; Biomarkers; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Complement C3; Female; Humans; Inflammation; Interleukin-1; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis, Continuous Ambulatory; Protein Precursors; Tumor Necrosis Factor-alpha | 2012 |
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.
Topics: Acetylcysteine; Aged; Comorbidity; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Free Radical Scavengers; Humans; Iopamidol; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 2002 |
Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Aged; Cardiac Catheterization; Contrast Media; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recovery of Function; Triiodobenzoic Acids | 2003 |
The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Endpoint Determination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Survival Analysis; Treatment Outcome | 2003 |
The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography.
Topics: Acetylcysteine; Aged; Angiography; Antioxidants; Creatinine; Double-Blind Method; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide; Oxidative Stress | 2003 |
Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Single-Blind Method; Stroke Volume; Treatment Outcome | 2003 |
Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure.
Topics: Acetylcysteine; Aged; Antioxidants; Blood Pressure; Cross-Over Studies; Endothelium, Vascular; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Vasodilation | 2004 |
Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubules; Male; Middle Aged; Oxidative Stress; Risk Factors | 2004 |
Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Free Radical Scavengers; Humans; Infusions, Intravenous; Iron; Kidney; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Models, Biological; Oxidative Stress; Transferrin | 2004 |
[Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Humans; Ioxaglic Acid; Kidney Failure, Chronic; Male; Prospective Studies; Treatment Failure | 2003 |
Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Malondialdehyde; Oxidative Stress; Pilot Projects; Probability; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Single-Blind Method | 2005 |
Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients.
Topics: Acetylcysteine; Aged; Antioxidants; Area Under Curve; Blood Urea Nitrogen; Cysteine; Drug Administration Schedule; Expectorants; Female; Glutathione; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Pilot Projects; Renal Dialysis | 2005 |
Renoprotective effect of high periprocedural doses of oral N-acetylcysteine in patients scheduled to undergo a same-day angiography.
Topics: Acetylcysteine; Administration, Oral; Aged; Angiography; Antioxidants; Contrast Media; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Prospective Studies | 2004 |
Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Topics: Acetylcysteine; Acetylglucosaminidase; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Creatinine; Cystatin C; Cystatins; Double-Blind Method; Female; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Complications; Preanesthetic Medication; Prospective Studies; Treatment Failure; Water-Electrolyte Balance | 2006 |
Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease.
Topics: Acetylcysteine; Adult; Aged; Blood Pressure; Blood Proteins; Diabetic Nephropathies; Drug Administration Schedule; Female; Heart Rate; Hematocrit; Homocysteine; Humans; Hypertension; Infusions, Intravenous; Kidney Calculi; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Urticaria | 2006 |
Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Aged; Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Bacteremia; Cysteine; Female; Gentamicins; Glutathione; Hearing Loss; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Prospective Studies; Renal Dialysis | 2007 |
Prevention of contrast-induced nephropathy in vascular surgery patients.
Topics: Acetylcysteine; Ambulatory Care; Aneurysm; Angiography; Contrast Media; Creatinine; Female; Fluid Therapy; Follow-Up Studies; Free Radical Scavengers; Hospitalization; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Peripheral Vascular Diseases; Placebos; Prospective Studies; Risk Factors; Vascular Surgical Procedures | 2007 |
Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients.
Topics: Acetylcysteine; Adult; Aged; Arginine; Biomarkers; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Treatment Outcome | 2008 |
N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Topics: Acetylcysteine; Aged; Cardiac Surgical Procedures; Dopamine Agonists; Double-Blind Method; Female; Fenoldopam; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Postoperative Complications; Prospective Studies | 2008 |
Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Arteriosclerosis; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1996 |
Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Aged; Antioxidants; Blood Urea Nitrogen; Contrast Media; Creatinine; Female; Free Radical Scavengers; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 2000 |
33 other study(ies) available for acetylcysteine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Topics: Acetylcysteine; Animals; Arteriovenous Fistula; Arteriovenous Shunt, Surgical; Female; Kidney Failure, Chronic; Male; Mice; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |
Protective effect of N-acetylcysteine on progression to end-stage renal disease: Necessity for prospective clinical trial.
Topics: Acetylcysteine; Adolescent; Adult; Comorbidity; Disease Progression; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Propensity Score; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Risk Reduction Behavior; Survival Analysis; Taiwan; Young Adult | 2017 |
Metabolomic Analysis of N-acetylcysteine Protection of Injury from Gadolinium-DTPA Contrast Agent in Rats with Chronic Renal Failure.
Topics: Acetylcysteine; Animals; Contrast Media; Gadolinium DTPA; Kidney Failure, Chronic; Male; Metabolomics; Rats; Rats, Sprague-Dawley | 2017 |
N-Acetylcysteine and Sulodexide Reduce the Prothrombotic Effect of Uremic Serum on the Venous Endothelial Cells.
Topics: Acetylcysteine; Anticoagulants; Blood Specimen Collection; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Female; Free Radical Scavengers; Glycosaminoglycans; Humans; Kidney Failure, Chronic; Male; Thrombosis; Uremia | 2019 |
N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1.
Topics: Acetylcysteine; Albumins; Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Body Weight; Cholesterol; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Kidney Failure, Chronic; Lipid Peroxidation; Lipids; Lipoproteins; Macrophages; Male; Mice; Nephrectomy; Oxygen; Rats; Rats, Wistar; Serum Albumin | 2014 |
Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
Topics: Acetylcysteine; Aged; Angiography; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Sodium Bicarbonate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2008 |
Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Creatinine; Cystatin C; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 2010 |
Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate.
Topics: Acetylcysteine; Animals; Benzothiazoles; Cell Line; Cell Proliferation; Cellular Senescence; Fibrosis; Humans; Indican; Kidney Failure, Chronic; Kidney Tubules, Proximal; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Toluene; Tumor Suppressor Protein p53 | 2010 |
Hemodialysis-associated pseudoporphyria resistant to N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Adult; Chloroquine; Drug Resistance; Female; Humans; Kidney Failure, Chronic; Porphyrias; Renal Dialysis; Skin; Treatment Failure | 2011 |
Therapy of hyperhomocysteinemia in hemodialysis patients: effects of folates and N-acetylcysteine.
Topics: Acetylcysteine; Aged; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2012 |
N-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity.
Topics: Acetylcysteine; Animals; Chelating Agents; Gadolinium; Glomerular Filtration Rate; Inulin; Kidney; Kidney Failure, Chronic; Male; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2012 |
Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes.
Topics: Acetylcysteine; Animals; Cell Adhesion; Cell Movement; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Endothelial Cells; Extracellular Matrix Proteins; Fibronectins; Kidney; Kidney Failure, Chronic; Male; Mice; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Osteopontin; Vascular Endothelial Growth Factor A | 2013 |
Does N-acetylcysteine modulate post-translational modifications of transthyretin in hemodialysis patients?
Topics: Acetylcysteine; Aged; Case-Control Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prealbumin; Protein Binding; Protein Processing, Post-Translational; Renal Dialysis | 2013 |
Protection from contrast-induced nephropathy: is the answer in?
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Triiodobenzoic Acids | 2003 |
A drug to prevent renal failure?
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Cysteine; Humans; Kidney Failure, Chronic; Meta-Analysis as Topic; Terminology as Topic | 2003 |
Successful direct stenting guided by intravascular ultrasound without contrast in a patient with renal dysfunction.
Topics: Acetylcysteine; Blood Vessel Prosthesis Implantation; Cardiac Catheterization; Coronary Stenosis; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Male; Middle Aged; Stents; Ultrasonography, Interventional | 2003 |
Role of acetylcysteine in the prevention of contrast-media-induced nephrotoxicity.
Topics: Acetylcysteine; Acute Kidney Injury; Administration, Oral; Antidotes; Cardiac Catheterization; Contrast Media; Creatinine; Databases, Factual; Endpoint Determination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2003 |
Renal disease, homocysteine, and cardiovascular complications.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Risk Factors | 2004 |
N-acetylcysteine to prevent contrast nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Angina Pectoris; Cardiac Catheterization; Contrast Media; Coronary Angiography; Humans; Kidney Failure, Chronic; Male | 2004 |
Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis.
Topics: Acetylcysteine; Adolescent; Annexin A5; Antioxidants; Apoptosis; Case-Control Studies; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Child; Child, Preschool; Female; Humans; Intracellular Membranes; Kidney Failure, Chronic; Male; Oxidative Stress; T-Lymphocytes | 2005 |
[Influence of vitamin E and N-acetylcysteine on intracellular oxidative stress in T lymphocytes in children treated with dialysis].
Topics: Acetylcysteine; Adolescent; Adult; Antigens, CD; Antioxidants; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Kidney Failure, Chronic; Male; Oxidation-Reduction; Oxidative Stress; Poland; Renal Dialysis; Statistics, Nonparametric; T-Lymphocytes; Time Factors; Treatment Outcome; Vitamin E | 2005 |
N-acetylcysteine attenuates the progression of chronic renal failure.
Topics: Acetylcysteine; Aldosterone; Animals; Antioxidants; Drug Therapy, Combination; Glomerular Filtration Rate; Kidney Failure, Chronic; Lipid Peroxidation; Male; Mineralocorticoid Receptor Antagonists; Nephrectomy; Rats; Rats, Wistar; Spironolactone | 2005 |
[The antioxidant therapy modulates intracellular lymphokine expression in children on dialysis].
Topics: Acetylcysteine; Adolescent; Adult; Antioxidants; Child; Child, Preschool; Humans; Infant; Interferon-gamma; Interleukin-4; Interleukin-6; Kidney Failure, Chronic; Lymphokines; Male; Oxidative Stress; Peritoneal Dialysis; Poland; Renal Dialysis; T-Lymphocytes; Treatment Outcome; Vitamin E | 2006 |
Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis.
Topics: Acetylcysteine; Administration, Oral; Aged; Antiviral Agents; Hand Dermatoses; Humans; Kidney Failure, Chronic; Male; Porphyrias; Renal Dialysis | 2006 |
Renal protection by N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Research Design | 2007 |
Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Cardiac Surgical Procedures; Evidence-Based Medicine; Humans; Kidney Failure, Chronic; Research Design | 2007 |
Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
Topics: Acetylcysteine; Acrolein; Aged; Aryldialkylphosphatase; Cysteine; Female; Humans; Kidney Failure, Chronic; Lipoproteins, HDL; Male; Middle Aged; Renal Dialysis; Treatment Outcome | 2007 |
N-Acetylcysteine in the prevention of ototoxicity.
Topics: Acetylcysteine; Administration, Oral; Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Bacteremia; Gentamicins; Hearing Loss; Humans; Kidney Failure, Chronic; Renal Dialysis | 2007 |
[Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease].
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Cardiac Catheterization; Contrast Media; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies | 2007 |
Is homocysteine toxic in uremia?
Topics: Acetylcysteine; Antitoxins; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Myocardial Infarction; Recurrence; Reference Values; Renal Dialysis; Retrospective Studies; Risk Factors; Uremia | 2008 |
Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
Topics: Acetylcysteine; Antioxidants; Contrast Media; Free Radical Scavengers; Humans; Kidney; Kidney Failure, Chronic | 2000 |
[Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Free Radical Scavengers; Humans; Iodine; Kidney Failure, Chronic; Randomized Controlled Trials as Topic | 2001 |
Sulfate conjugation in drug metabolism: role of inorganic sulfate.
Topics: Acetaminophen; Acetylcysteine; Animals; Arylsulfotransferase; Biotransformation; Chemical and Drug Induced Liver Injury; Computers; Humans; Kidney Failure, Chronic; Kinetics; Rats; Salicylamides; Sulfates; Sulfurtransferases | 1986 |